Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Anxiety Disorders [[electronic resource] ] : Rethinking and Understanding Recent Discoveries / / edited by Yong-Ku Kim
| Anxiety Disorders [[electronic resource] ] : Rethinking and Understanding Recent Discoveries / / edited by Yong-Ku Kim |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (VII, 576 p. 32 illus., 25 illus. in color.) |
| Disciplina | 616.8522 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
Neurosciences
Neurobiology Neuropsychology |
| ISBN | 981-329-705-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1. Brain network concepts -- Chapter 1. Task MRI-based functional brain network of anxiety -- Chapter 2. Phenotype network and brain structural covariance network of anxiety -- Chapter 3. linear/nonlinear micro-and-macro state EEG-based functional networks for anxiety -- Chapter 4. White matter-based structural brain network of anxiety -- Chapter 5. Resting state abnormalities in anxiety disorders and spatiotemporal psychopathology -- Part 2. Neurobiological Aspects -- Chapter 6. Gene-environmental interactions and role of epigenetics in anxiety disorders -- Chapter 7. The role of the oxytocin system in anxiety disorders -- Chapter 8. Translational studies in the complex roles of neurotransmitter systems in anxiety and anxiety disorders -- Chapter 9. The role of early life stress in HPA axis dysfunction in anxiety disorders -- Chapter 10. Immune-kynurenine pathways and the gut-microbiota-brain axis in anxiety disorders -- Chapter 11. Experimental anxiety model for anxiety disorders: relevance to drug discovery -- Part 3. Diagnostic and clinical Issues -- Chapter 12. Anxiety disorders in DSM-5: changes, controversies, and future directions -- Chapter 13. Biological markers to differentiate the type of anxiety disorders -- Chapter 14. Comorbid anxiety and depression: clinical and conceptual consideration, transdiagnostic treatment -- Chapter 15. Anxiety disorders and medical comorbidity: treatment implications -- Part 4. Therapeutic Issues -- Chapter 16. Biofeedback and Neurofeedback for Anxiety Disorders: A Quantitative and Qualitative Systematic Review -- Chapter 17. Cognitive Behavioral Therapy, Mindfulness-Based Cognitive Therapy and Acceptance Commitment Therapy for Anxiety Disorders: Integrating Traditional with Digital Treatment Approaches -- Chapter 18. Neurostimulation in anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder -- Chapter 19. Current and novel psychopharmacological drugs for anxiety disorders -- Chapter 20. Role of benzodiazepines in anxiety disorders -- Chapter 21. Virtual Reality for Anxiety Disorders: Rethinking a Field in Expansion -- Chapter 22. Current research on complementary and alternative medicine (CAM) in the treatments of anxiety disorders: evidence based review -- Chapter 23. Contemporary Psychodynamic Approaches to Treating Anxiety: Theory, Research, and Practice -- Chapter 24. Well-being therapy in anxiety disorders -- Part 5. Anxiety and precision psychiatry -- Chapter 25. Personalized clinical approaches to anxiety disorders -- Chapter 26. The role of hormonal and reproductive status in the treatment of anxiety disorders in women -- Chapter 27. Risk factors and prevention strategies for anxiety disorders in childhood and adolescence -- Chapter 28. Anxiety disorders in the elderly. |
| Record Nr. | UNINA-9910373940303321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Frontiers in Psychiatry [[electronic resource] ] : Artificial Intelligence, Precision Medicine, and Other Paradigm Shifts / / edited by Yong-Ku Kim
| Frontiers in Psychiatry [[electronic resource] ] : Artificial Intelligence, Precision Medicine, and Other Paradigm Shifts / / edited by Yong-Ku Kim |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XI, 641 p. 21 illus., 17 illus. in color.) |
| Disciplina | 611.01816 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
Molecular biology
Neurosciences Laboratory medicine Psychiatry Molecular Medicine Laboratory Medicine Intel·ligència artificial |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-329-721-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part 1. Challenges and Strategies -- Chapter 1. Challenges of Big Data and Discovery Sciences in Psychiatry -- Chapter 2. Challenges and Strategies for the Classification of Psychiatric Disorders -- Chapter 3. Genetic markers of Alzheimer’s disease -- Chapter 4. Genetic markers in Psychiatry -- Chapter 5. Recent advances in Neuroimaging of Small Vessel Disease in Late-life Depression -- Part 2. Advances in artificial intelligence technologies -- Chapter 6. Artificial Intelligence in Psychiatry -- Chapter 7. Machine Learning in Neural Networks: Clinical Opportunity of a Paradigm Shift -- Chapter 8. Imaging Connectomics: A new insights for understanding brain diseases -- Chapter 9. Development of Neuroimaging–based Biomarkers in Psychiatry: back to the future -- Part 3. Research methods for Precision Medicine -- Chapter 10. Precision Psychiatry: Biomarker guided Tailored Therapy for Effective Treatment and Prevention -- Chapter 11. Women Psychiatry: Do we need a New Paradigm? -- Chapter 12. CHILD PSYCHIATRY: What We Know and What We Don’t Know on Mood Disorders -- Chapter 13. The frontiers of suicide -A global threat or global phenomenon -- Part 4. Ongoing paradigm shifts -- Chapter 14. Animal Research in psychiatry: a paradigm shift -- Chapter 15. Modeling psychiatric diseases with induced pluripotent stem (iPS) cells -- Chapter 16. Paradigm Shift in Psychopharmacology and Psychotherapy Research -- Chapter 17. More integrated Bio-Psycho-Social approach to Psychiatric Disorders -- Chapter 18. Early Identification of Psychiatric Disorders: do we need a paradigm shift? -- Part 5. New Theoretical frameworks for Research -- Chapter 19. Theoretical psychiatry: Missing link between academic and clinical psychiatry for further scientific and professional maturation of psychiatry -- Chapter 20. Theoretical psychiatry and transdisciplinary integrative approach: Stepping stones to precision and person-centered psychiatry -- Chapter 21. Developmental Psychopathology: Application to Psychiatry -- Chapter 22. Emotion: Concepts and Dysfunctions in Neuropsychiatric Research -- Chapter 23. Resilience: A Psychopathological Construct for Psychiatric Disorders -- Chapter 24. Inflammation for psychiatric disorders: Fact or Hypothesis -- Chapter 25. Smart Healthcare System and Precision Medicine: through the Brain Mechanisms of the Smartphone and Internet Game Addiction -- Part 6. Novel interventions -- Chapter 26. Telomere-telomerase system in psychiatric disorders and it’s role in treatment -- Chapter 27. Neuromodulation on Cognitive Control of Emotion: a paradigm shift -- Chapter 28. Psychobiotics: A paradigm shift in Psychopharmacology -- Chapter 29. Digital Interventions for Mental Disorders: Key Features, Efficacy, and Potential for Artificial Intelligence Applications -- Chapter 30. Cognitive behavioral therapy for insomnia using internet, mobile application, and wearable devices. |
| Record Nr. | UNINA-9910373918603321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Major depressive disorder : rethinking and understanding recent discoveries / / Yong-Ku Kim, editor
| Major depressive disorder : rethinking and understanding recent discoveries / / Yong-Ku Kim, editor |
| Pubbl/distr/stampa | Singapore : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (555 pages) |
| Disciplina | 616.8527 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
Depression, Mental
Depression, Mental - Pathogenesis Depression, Mental - Treatment Depressió psíquica Etiologia Terapèutica |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-336-044-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910483674603321 |
| Singapore : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Major depressive disorder : cognitive and neurobiological mechanisms / / edited by Yong-Ku Kim
| Major depressive disorder : cognitive and neurobiological mechanisms / / edited by Yong-Ku Kim |
| Pubbl/distr/stampa | Rijeka, Croatia : , : InTech, , [2015] |
| Descrizione fisica | 1 online resource (viii, 145 pages) : illustrations |
| Disciplina | 616.8527 |
| Soggetto topico | Depression, Mental - Psychological aspects |
| ISBN |
953-51-7240-9
953-51-2129-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti |
Major depressive disorder
Major Depressive Disorder - Cognitive and Neurobiological Mechanisms |
| Record Nr. | UNINA-9910131439603321 |
| Rijeka, Croatia : , : InTech, , [2015] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neuroinflammation, gut-brain axis and immunity in neuropsychiatric disorders / / edited by Yong-Ku Kim
| Neuroinflammation, gut-brain axis and immunity in neuropsychiatric disorders / / edited by Yong-Ku Kim |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore Pte Ltd, , [2023] |
| Descrizione fisica | 1 online resource (564 pages) |
| Disciplina | 616.3 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
Gastrointestinal system - Microbiology
Nervous system - Diseases - Microbiology |
| ISBN |
9789811973765
9789811973758 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1.How Immune-inflammatory processes link neurodegenerative and psychiatric disorders -- 2.Gut-Microbiota-Brain Axis: pathophysiological mechanism in neuropsychiatric disorders -- 3.Microbiome- induced autoimmunity and novel therapeutic intervention -- 4.The key role of microlia and circulating monocytes in etipathology neuropsychiatric disorders -- 5.Neuro-immuno-epigenetics of prenatal psychological stress -- 6.C-reactive protein (CRP): a potent inflammation biomarker in psychiatric disorders -- 7.Neuroinflammation, neurognesis and neuroprotection in schizophrenia -- 8.Autoimmue psycosis: concept, clinical manifestation and management -- 9.Stress, autonomic nervous system and kynurenine pathway in major depression -- 10.Brain-gut-microbiome axis in major depression : novel therapeutic approach -- 11.Glial-Neuronal Interaction in Synapses: A Possible Mechanism of the Pathophysiology of Bipolar Disorder -- 12.Neuroimmaging of inflammation in depression and anxiety disorders -- 13.Neuroinflammation and immune-kynureinine pathway in anxiety disorders -- 14.Inflammatory-mediated responses in development of neurogeneartive diseases -- 15.The connection between gut-brain axis and PTSD -- 16.Eating disorders : Gut microbiota-immune-brain interactions -- 17.Sleep-immune crosstalk and sleep disorders -- 18.Obsessive-compulsive disorder: immuno-inflammatory disorder? -- 19.Cytokine, neuroinflammation and neurodeneration in Alzheimer’s disease -- 20.Molecular imaging of neuroinflammation in Alzheimer's disease and MCI -- 21.The role of N-Methyl-D-Aspartate Receptor Neurotransmission and mictobiota in Alzheimer’s disease -- 22.Neuroglial activation and neuroinflammation in the brain of patients with autism -- 23.Suicide and inflammation -- 24.Anti-inflammatory effect of Traditional Chinese Medicine on the concept of Mind-body interface -- 25.Anti-inflammatory therapy as a promising target in neupsychiatric disorders. |
| Record Nr. | UNINA-9910683355503321 |
| Singapore : , : Springer Nature Singapore Pte Ltd, , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Treatment Resistance in Psychiatry [[electronic resource] ] : Risk Factors, Biology, and Management / / edited by Yong-Ku Kim
| Treatment Resistance in Psychiatry [[electronic resource] ] : Risk Factors, Biology, and Management / / edited by Yong-Ku Kim |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (415 pages) |
| Disciplina | 616.89 |
| Soggetto topico | Psychiatry |
| ISBN | 981-10-4358-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I. Rethinking the treatment resistance in psychiatry -- Chapter 1. Definition and epidemiology of treatment resistance in psychiatry -- Chapter 2. Paradigm shift in study of treatment resistant psychiatric disorder -- Chapter 3. Genetic factors underlying treatment resistance in psychiatry -- Chapter 4. Using neuroimaging and electroencephalography for prediction of treatment resistance in psychiatric disorders -- Chapter 5. Developing therapies for treatment-resistant depressive disorders in animal models -- Chapter 6. Integrated approaches to treatment-resistant psychiatric disorders -- Part II. Treatment resistance in specific disorders -- Chapter 7. Treatment resistant depression: understandings on the neurobiological etiology that lead to novel pharmacological treatment options -- Chapter 8. Treatment Resistant Schizophrenia: assessment and management -- Chapter 9. Treatment resistance in bipolar disorders -- Chapter 10. Treatment resistance in post-traumatic stress disorder -- Chapter 11. Treatment resistance in obsessive compulsive disorder -- Chapter 12. Treatment of opioid dependence -- Chapter 13. Treatment-resistant panic disorder -- Chapter 14. Treatment resistance in anxiety disorder: generalized anxiety disorder, social anxiety disorder -- Chapter 15. Treatment resistance in Attention-Deficit Hyperactivity Disorder -- Chapter 16. Treatment resistance in Tourette syndrome -- Chapter 17. Treatment-Resistance Eating Disorders -- Chapter 18. Comorbid sleep and wake problems in treatment-resistant psychiatric conditions -- Part III. Therapeutic intervention for treatment resistance -- Chapter 19. Creative, person-centered psychopharmacology for treatment resistance in psychiatry -- Chapter 20. A psychodynamic approach to treatment resistance -- Chapter 21. Cognitive behavioral therapy and behavioral activation therapy for treatment resistant depression: traditional and digital therapy perspectives -- Chapter 22. Novel neurostimulation therapeutic approaches for treatment resistant psychiatric disorders -- Chapter 23. When clozapine fails: augmentation strategies in the management of clozapine-resistant schizophrenia -- Chapter 24. Fecal microbiota transplantation in the treatment resistant psychiatric disorders -- Chapter 25. Neurosurgical intervention for treatment-resistant psychiatric disorders. |
| Record Nr. | UNINA-9910337484903321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Understanding Depression [[electronic resource] ] : Volume 2. Clinical Manifestations, Diagnosis and Treatment / / edited by Yong-Ku Kim
| Understanding Depression [[electronic resource] ] : Volume 2. Clinical Manifestations, Diagnosis and Treatment / / edited by Yong-Ku Kim |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (XIII, 327 p. 21 illus., 18 illus. in color.) |
| Disciplina | 616.8 |
| Soggetto topico |
Neurology
Psychiatry Clinical psychology Neurobiology Neurosciences Neurology Clinical Psychology |
| ISBN | 981-10-6577-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1.Diagnostic issues of depression -- 1-1.Major depression and bipolar depression: similarity, difference and contemporary treatment approach -- 1-2.Biomarkers of depression-potential diagnostic tools -- 1-3.Diagnosis of depression: from clinical classification to biological classification -- 1-4.Application of neuroimaging in the diagnosis and treatment in depression -- 2.Clinical manifestations of depression -- 2-1.Anhedonia as a crucial factor of depression; assessment, neurobiological underpinning and treatment -- 2-2.Sleep and sleep disorders in depression -- 2-3.Chronobiology and treatment in depression -- 2-4.Suicide in depression: risk factors, neurobiology and treatment -- 2-5.Cognitive dimension of depression; assessment, neurobiology and treatment -- 2-6.Risk factors and prevention strategy of depression in childhood and adolescence -- 2-7.Neurobiology and risk factors in late life depression -- 3.Complicated clinical manifestations of depression -- 3-1.Overlapping chronic pain and depression: pathophysiology and management -- 3-2.Clinical, biological and therapeutic characteristics between depression with and without medical illness -- 3-3.Biological mechanism underlying the link Depression and cardiovascular disease -- 3-4.Bunout syndrome and depression -- 3-5.The link between obesity and depression: exploring shared mechanisms -- 3-6.Biomarkers, detection and therapeutic approaches for antenatal and postnatal depression -- 4.Therapeutic issues of depression -- 4-1.Ketamine: a promising rapid-acting antidepressant in depression -- 4-2.Antidepressant therapy for depression: An update -- 4-3.The use of atypical antipsychotics in treatment of depression: efficacy and safety -- 4-4.Neurobiology and therapeutic approach in treatment-resistant depression (TRD) -- 4-5.Clinical application of neurostimulation in depression -- 4-6.Combination therapy of pharmacotherapy and psychotherapy in depression: Is it really superior to either treatment alone? -- 4-7.Mindfulness-based cognitive therapy for depression: preference to internet-based mental health and psychotherapy approaches in mood disorders -- 4-8.Current research on complementary and alternative medicine (CAM) in the treatments of depression: evidence based review. |
| Record Nr. | UNINA-9910300445903321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Understanding Depression [[electronic resource] ] : Volume 1. Biomedical and Neurobiological Background / / edited by Yong-Ku Kim
| Understanding Depression [[electronic resource] ] : Volume 1. Biomedical and Neurobiological Background / / edited by Yong-Ku Kim |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (XIII, 322 p. 16 illus., 14 illus. in color.) |
| Disciplina | 616.8 |
| Soggetto topico |
Psychiatry
Neurology Neurosciences Molecular biology Pharmaceutical technology Medical biochemistry Neurology Molecular Medicine Pharmaceutical Sciences/Technology Medical Biochemistry |
| ISBN | 981-10-6580-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1.Genetic and epigenetic aspects of depression -- 1-1.Highlights on pharmacogenetics and pharmacogenomics in depression -- 1-2.Imaging genetics studies on susceptibility genes for major depressive disorder: the present and the future -- 1-3.Gene-environmental interaction and role of epigenetic in depression -- 1-4.The role of microRNAs and long noncoding RNAs in depression: diagnosis and therapeutic implication -- 1-5.The role of early life stress in HPA axis and depression -- 2.Molecular-, cellular-level aspects of depression -- 2-1.Complex role of serotonin receptors in depression -- 2-2.Emerging role of glutamate receptors in pathophysiology of depression -- 2-3.New perspective on mTOR pathways: a new target of depression -- 2-4.Cellular aging in depression: the role of telomere-telomerase system -- 2-5.Differentiation and biological markers in subtype of depression -- 3.Neural circuit-level aspect of depression -- 3-1.Molecular, structural, and functional neuroimaging in depression -- 3-2.Resting-state activity in depression; a link to spatiotemporal psychopathology -- 3-3.Functional neuroimaging in depression: a tool to predict treatment outcome and response -- 3-4.Cortical-subcortical interactions in the pathophysiology of depression -- 3-5.Pathophysiology and treatment strategies for different types of depression -- 3-6.The effect of neurostimulation in depression -- 4.Multicellular system-level aspect of depression -- 4-1.Inflammation, depression and neurodegeneration: a possible cause of dementia in late life depression? -- 4-2.Gut-microbiota-brain axis and depression -- 4-3.The interactions of immune inflammation and oxidative and nitrosative stress with the kynurenine and melatonergic pathways in depression -- 4-4.Glia-neuron cross-talk in depression -- 4-5.Depression model in primate: relevance to novel drug discovery -- 5.Species-, individual-, gender-, culture-specific aspects of depression -- 5-1.Precision psychiatry: personalized clinical approach to depression -- 5-2.Gender differences in depression -- 5-3.An up-date on the epidemiology of major depressive disorder across cultures. |
| Record Nr. | UNINA-9910300445603321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||